Associate Director HTS
AstraZeneca, United Kingdom
I am an Associate Director in High Throughput Screening in AstraZeneca. I completed a PhD in Drug Delivery and Targeted Therapeutics at the University of Nottingham. I joined AstraZeneca in 2016 in the Safety Profiling Team in Mechanistic Biology and Profiling, where I pioneered a suite of in vitro assays aiming to predict Drug-Induced Liver Injury using 3D cultures, high-content imaging methods and machine learning. I enjoy working at the interface of chemistry, biology and data science. I am passionate about leading and developing a high-performing team to leverage HTS data and deliver impact from cell-based assays.